#FindingSolutions Breakfast | Friday, October 4

Young Researchers Roundtable Breakfast Brings Voice to Those Living with Metastatic Breast Cancer 

Presented by Pfizer Oncology

RALEIGH, NC – Susan G. Komen® North Carolina Triangle to the Coast will host its sixth annual Young Researchers Roundtable Breakfast: Hearing the Metastatic Voice, bringing attention and urgency to metastatic breast cancer (MBC) treatment, support, and needed research.

Metastatic breast cancer (MBC), also called stage IV or advanced breast cancer, is breast cancer that has spread beyond the breast to other organs in the body (most often the bones, lungs, liver or brain.) MBC is not a type of breast cancer, but rather the most advanced stage of all types of breast cancer. It causes the majority of the 42,000 expected breast cancer deaths each year in the U.S. Both women and men can be diagnosed with MBC. In the U.S., it’s estimated at least 154,000 people are currently living with MBC.

“Our Bold Goal at Komen is to reduce the current number of breast cancer deaths by 50% in the U.S. by 2026. The key to reaching this goal is MBC research,” said Pam Kohl, executive director at Komen North Carolina Triangle to Coast. “It is research that will cure this disease, and until then, it is research that will transform MBC from terminal to chronic, giving patients and their families the priceless gift of time.”

With the support of presenting sponsor, Pfizer Oncology, the program will consist of panelist presentations by individuals vested in MBC research and treatment including Dr. Charles Perou, at UNC Lineberger Comprehensive Cancer Center, Dr. Anthony Galanos, Palliative Medicine Specialist at Duke Cancer Institute, Dr. Sarah Sammons, Medical Oncologist at Duke Cancer Institute, and Elizabeth Levene, executive director at Helps Education Fund and living with MBC.

The roundtable event is unique opportunity connecting early-career breast cancer researchers with established local Komen Scholars, physicians, scientists, individuals living with MBC, breast cancer survivors, and co-survivors in a meaningful way. The breakfast will be held on Friday, October 4, 2019, from 9:15 a.m. to 12:30 p.m., at The Washington Duke Inn at 3001 Cameron Blvd., in Durham, NC.

In addition to the panel program, the following young researchers from local institutions in the Triangle will provide brief overviews of their breast cancer research projects:

  • Susana Garcia Recio, The University of North Carolina at Chapel Hill
  • Hamzah Kharabsheh, Komen Graduate Training in Disparities Research Trainee, North Carolina Central University
  • Taylor Krebs, Duke University
  • Linnea Olsson, The University of North Carolina at Chapel Hill

Following the researcher overviews, there will be table discussions about breast cancer research and treatment and its impact on patient care with a focus on the care of those living with MBC.

The breakfast is the first event in Komen NCTC’s Finding Solutions Research Series highlighting the important work taking place in laboratories locally and nationally toward finding the cures to breast cancer. Comprised of three events, Komen’s series brings together a passionate audience of researchers, advocates, and those impacted by breast cancer.

Click here for event details and registration.


About Susan G. Komen® North Carolina Triangle to the Coast

Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Komen was founded in 1982 by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Komen NC Triangle to the Coast is working to better the lives of those facing breast cancer in the local community. Komen NC Triangle to the Coast has invested more than $14 million in community breast health programs in its 29-county service area and has helped contribute over $5 million to the more than $988 million invested globally in researchFor more information, call (919) 493-2873 or visit komennctc.org.


Contact:    Krista Park Berry, Development and Communications Director